Head and Neck Cancer News & Features
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
A majority of patients enrolled in a phase 1 trial of CUDC-101 were found to be free progression at 1.5 years of median follow-up, according to a published report.
Investigators have uncovered genomic differences, with potentially important clinical implications, in head and neck cancers caused by infection with the human papillomavirus.
Significant benefits of exercise regimen in reducing the effect of percutaneous endoscopic gastrostomy placement on swallowing function for patients with head and neck cancer.
The addition of head and neck cancer screenings to regular lung cancer screenings could improve early detection and survival, according to published research.
Head and Neck Cancer Clinical Trials
- Drug combination suppresses growth of late-stage prostate cancer tumors
- Ultrasound helps determine which breast cancer patients need lymph nodes removed
- California breast density law slow to have an impact
- Epigenetic signatures differentiate triple negative breast cancers
- New treatment method shrinks ovarian cancer tumors and improves chemotherapy effectiveness
- What determines cost-effectiveness of targeted anticancer therapies?
- Physician-controlled decisions in cancer care linked to lower quality rating
- Transfusion Indications for Patients With Cancer
- Lung cancer may be treatable with use of SapC-DOPS technology
- What autism can teach us about brain cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|